ʻO ka PCR Fluorescence

Multiplex PCR manawa maoli | ʻenehana ʻenekini hoʻoheheʻe | pololei | Pūnaehana UNG | Ka wai a me ka lyophilized reagent

ʻO ka PCR Fluorescence

  • Neisseria Gonorrhoeae Nucleic Acid

    Neisseria Gonorrhoeae Nucleic Acid

    Hoʻolālā ʻia kēia pahu no ka ʻike in vitro o Neisseria Gonorrhoeae(NG) nucleic acid i loko o ka mimi kāne, ka urethral swab kāne, ka wahine cervical swab samples.

  • ʻEhā ʻano o nā mea hoʻomaʻi hanu nucleic acid

    ʻEhā ʻano o nā mea hoʻomaʻi hanu nucleic acid

    Hoʻohana ʻia kēia kit no ka ʻike qualitative o SARS-CoV-2, influenza A virus, influenza B virus a me respiratory syncytial virus nucleic acids i loko o nā ʻano oropharyngeal swab samples.

  • ʻO ka Mycobacterium Tuberculosis Rifampicin Resistance

    ʻO ka Mycobacterium Tuberculosis Rifampicin Resistance

    He kūpono kēia pahu no ka ʻike qualitative o ka homozygous mutation i loko o ka 507-533 amino acid codon māhele o ka rpoB gene i kumu kū'ē i ka Mycobacterium tuberculosis rifampicin.

  • ʻO ka Cytomegalovirus kanaka (HCMV) Nucleic Acid

    ʻO ka Cytomegalovirus kanaka (HCMV) Nucleic Acid

    Hoʻohana ʻia kēia pahu no ka hoʻoholo ʻana i ka qualitative o nā waikawa nucleic i nā laʻana me ka serum a i ʻole ka plasma mai nā mea maʻi i manaʻo ʻia he maʻi HCMV, i mea e kōkua ai i ka hōʻoia ʻana o ka maʻi HCMV.

  • Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin Resistance

    Mycobacterium Tuberculosis Nucleic Acid a me Rifampicin Resistance

    He kūpono kēia kit no ka ʻike qualitative o Mycobacterium tuberculosis DNA i loko o nā laʻana sputum kanaka i loko o vitro, a me ka homozygous mutation i loko o ka 507-533 amino acid codon māhele o ka rpoB gene i kumu kū'ē i ka Mycobacterium tuberculosis rifampicin.

  • EB Virus Nucleic Acid

    EB Virus Nucleic Acid

    Hoʻohana ʻia kēia pahu no ka ʻike qualitative o EBV i ke koko holoʻokoʻa o ke kanaka, plasma a me nā laʻana serum in vitro.

  • Malaria Nucleic Acid

    Malaria Nucleic Acid

    Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o Plasmodium nucleic acid i nā laʻana koko peripheral o nā mea maʻi i manaʻo ʻia i ka maʻi Plasmodium.

  • HCV Genotyping

    HCV Genotyping

    Hoʻohana ʻia kēia pahu no ka ʻike genotyping o ka maʻi hepa C (HCV) subtypes 1b, 2a, 3a, 3b a me 6a i loko o nā laʻana serum/plasma o ka maʻi hepatitis C (HCV). Kōkua ia i ka ʻike a me ka mālama ʻana i nā maʻi HCV.

  • Adenovirus Type 41 Nucleic Acid

    Adenovirus Type 41 Nucleic Acid

    Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka qualitative o ka adenovirus nucleic acid i loko o nā ʻāpana stool in vitro.

  • Virus Dengue I/II/III/IV Nucleic Acid

    Virus Dengue I/II/III/IV Nucleic Acid

    Hoʻohana ʻia kēia kime no ka ʻike ʻana i ka denguevirus (DENV) nucleic acid i ka laʻana serum o ka mea maʻi i manaʻo ʻia no ke kōkua ʻana i ka maʻi me ka maʻi Dengue.

  • Helicobacter Pylori Nucleic Acid

    Helicobacter Pylori Nucleic Acid

    Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o ka helicobacter pylori nucleic acid i loko o ka gastric mucosal biopsy tissue samples a i ʻole saliva samples o nā mea maʻi i manaʻo ʻia ua loaʻa i ka maʻi helicobacter pylori, a hāʻawi i kahi ala kōkua no ka hōʻoia ʻana o nā maʻi me ka maʻi helicobacter pylori.

  • STD Multiplex

    STD Multiplex

    Hoʻolālā ʻia kēia pahu no ka ʻike qualitative o nā pathogens maʻamau o nā maʻi urogenital, me Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), Ureaplasma urealyticum (UU), Herpes Simplex Virus Type 1 (HSV1), Herpes Simplex Virus Type 2 (HSV2), Mycoplasma uricominis (Mnaplasma genital) male male. nā laʻana huna o ke kino.